# Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection

> **NCT02237859** · PHASE4 · UNKNOWN · sponsor: **Corewell Health West** · enrollment: 140 (estimated)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Vancomycin
- **DIETARY_SUPPLEMENT:** fruit juice/placebo

## Key facts

- **NCT ID:** NCT02237859
- **Lead sponsor:** Corewell Health West
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2014-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02237859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02237859, "Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02237859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*